Line 146: | Line 146: | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
Beginning of the synthesis of the Thiol-Eslicarbazepin in Toluen. | Beginning of the synthesis of the Thiol-Eslicarbazepin in Toluen. | ||
− | + | Eslicarbazepin was treated with 0.5 mole equivalent of Lawesson's reagent in Toluene. | |
Reflux at 120°C gave a yellow liquid with white solids. | Reflux at 120°C gave a yellow liquid with white solids. | ||
Purification with HPLC. | Purification with HPLC. | ||
Line 155: | Line 155: | ||
The MS-Data was examined. | The MS-Data was examined. | ||
MS-Data gave a yield of >10%. | MS-Data gave a yield of >10%. | ||
− | Drying of 1,2-dimethoxyethane with | + | Drying of 1,2-dimethoxyethane with CaH{{Tuebingen/Sub|2}} overnight. |
}} | }} | ||
{{Tuebingen/PlainSubHeading|15.08.2018}} | {{Tuebingen/PlainSubHeading|15.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | Distillation of 1,2-dimethoxyethane, treating with N{{Tuebingen/Sub|2}} for | + | Distillation of 1,2-dimethoxyethane, treating with N{{Tuebingen/Sub|2}} for inert storage. |
}} | }} | ||
{{Tuebingen/PlainSubHeading|16.08.2018}} | {{Tuebingen/PlainSubHeading|16.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | Alternative synthesis of the | + | Alternative synthesis of the Thiol-Eslicarbazepin treated with 1,2-dimethoxyethane (DME) at room temperature with 0.5 mole equivalent of Lawesson's reagent, (method OH->SH). |
}} | }} | ||
{{Tuebingen/PlainSubHeading|17.08.2018}} | {{Tuebingen/PlainSubHeading|17.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | Drying the | + | Drying the Thiol-Eslicarbazepin and purification by column chromatography (-> methods). |
A sample was taken and given to mass spectrometry. | A sample was taken and given to mass spectrometry. | ||
}} | }} | ||
{{Tuebingen/PlainSubHeading|20.08.2018}} | {{Tuebingen/PlainSubHeading|20.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | The MS-Data was examined | + | The MS-Data was examined showed indications of large impurities. |
− | + | Further purification of the Thiol-Eslicarbazepin by column chromatography. | |
− | Further purification of the | + | |
}} | }} | ||
{{Tuebingen/PlainSubHeading|21.08.2018}} | {{Tuebingen/PlainSubHeading|21.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | First attempt of the synthesis of the | + | First attempt of the synthesis of the azide-Donor (method Azid-D). Sodium azide was suspended in Sulfuryl chloride and stirred overnight. |
}} | }} | ||
{{Tuebingen/PlainSubHeading|22.08.2018}} | {{Tuebingen/PlainSubHeading|22.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | The azide mixture was treated with Imidazole and dried in vacuo. After suspending in ethyl acetate the solution was treated with sulfuric acid to yield a | + | The azide mixture was treated with Imidazole and dried in vacuo. After suspending in ethyl acetate the solution was treated with sulfuric acid to yield a crude, yellow solid. |
A sample was taken and given to mass spectrometry. | A sample was taken and given to mass spectrometry. | ||
}} | }} | ||
{{Tuebingen/PlainSubHeading|23.08.2018}} | {{Tuebingen/PlainSubHeading|23.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | The MS-Data was | + | The MS-Data was showed no yield. |
− | + | The second attempt for the synthesis of the azide-donor was started. | |
− | The second attempt for the synthesis of the | + | Sulfuryl chloride was treated with sodium azide and imidazole, suspended in acetonitrile and stirred for three hours. |
− | Sulfuryl chloride was treated with | + | The product was dried in vacuo, solved in ethyl acetate and treated with sulfuric acid. No product was obtained. |
− | The product was dried in vacuo, solved in ethyl acetate and treated with sulfuric acid | + | The third attempt for the synthesis of the azide-donor was started. |
− | The third attempt for the synthesis of the | + | An ice-cooled Suspension of sodium azide in acetonitrile was treated with Sulfuryl chloride. |
− | An ice-cooled Suspension of | + | |
Synthesis Disulfide-Eslicarbazepine was started. | Synthesis Disulfide-Eslicarbazepine was started. | ||
− | The synthesis was performed under inert conditions. The | + | The synthesis was performed under inert conditions. The Thiol-Eslicarbazepin was solved in THF/H{{Tuebingen/Sub|2}}O, treated with Cysteamine and stirred overnight. |
}} | }} | ||
{{Tuebingen/PlainSubHeading|24.08.2018}} | {{Tuebingen/PlainSubHeading|24.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | The ice-cooled solution of the | + | The ice-cooled solution of the azide was treated portion-wise with Imidazole. |
− | It was stirred | + | It was stirred for three hours, diluted with ethyl acetate, washed, saturated and treated with sulfuric acid. |
After stirring for one hour the crude, colorless product was obtained. | After stirring for one hour the crude, colorless product was obtained. | ||
The product was dried in vacuo. | The product was dried in vacuo. | ||
− | The solution of the S-S-Eslicarbazepine was | + | The solution of the S-S-Eslicarbazepine was in a rotary evaporator to obtain a crystalline, colorless solid. |
}} | }} | ||
{{Tuebingen/PlainSubHeading|27.08.2018}} | {{Tuebingen/PlainSubHeading|27.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | The S-S-Eslicarbazepine was further purified by washing with ethyl acetate | + | The S-S-Eslicarbazepine was further purified by washing with ethyl acetate. |
A sample of the S-S-Eslicarbazepine was taken and given to mass spectrometry. | A sample of the S-S-Eslicarbazepine was taken and given to mass spectrometry. | ||
}} | }} | ||
Line 214: | Line 212: | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
The MS-Data was examined. | The MS-Data was examined. | ||
− | MS-Data | + | MS-Data suggested the reaction was not carried out as the original reactants were reobtained. |
}} | }} | ||
{{Tuebingen/PlainSubHeading|29.08.2018}} | {{Tuebingen/PlainSubHeading|29.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | + | The reactants were dried with a rotary evaporator for further use, but Thio-Eslicarbazepine was destroyed due to it's instability in water. | |
}} | }} | ||
{{Tuebingen/PlainSubHeading|30.08.2018}} | {{Tuebingen/PlainSubHeading|30.08.2018}} | ||
{{Tuebingen/SingleContent| | {{Tuebingen/SingleContent| | ||
− | Destroying of the | + | Destroying of the azide-donor. |
}} | }} | ||
{{Tuebingen/PlainSubHeading|31.08.2018}} | {{Tuebingen/PlainSubHeading|31.08.2018}} |
Revision as of 15:50, 17 October 2018
Labwork
Everybody's a mad scientist, and life is their lab. We're all trying to experiment to find a way to live, to solve problems, to fend off madness and chaos.- David Cronenberg
Introduction
BoNT C - Liscense to enter
As stated, we modify botulinum toxin in a way that leads to its detoxification.
This, and the coupling to other substances was the main part of our Labwork, next to cell culture to test our library on neuron-like cells. The whole process that took place and different methods we used to archive our goals is described below.
An other important part of every iGEM year is the InterLab Study, which is one of the Bronze-Medal Criteria.
If you are intersted in our Bioinformatic part:
Methods
Working neatly is very important to every scientist. Because of this, here we're describing our methods. You can click any of the tabs to see what we did in each laboratory.
Generating Electrocompetent Cells
Transformation of Cells
Mini Preparation of Plasmid DNA
Maxi Preparation of Plasmid DNA
Restriction Digest and Ligation
This is a text
This is a text
Explanation of distillation
Explanation of chromatographie
Explanation how to dry solvents
Synthesis of the Thiol-Esli
Synthesis of the Disulfid-Esli
Synthesis of the Azid-Donor
Labbook
Here you can read our Labbook. It is the place, where we described everything that we did, and when. If you are interessted in our workflow, you can read everything below.
This is a text
This is a text
This is a text
13.08.2018
Beginning of the synthesis of the Thiol-Eslicarbazepin in Toluen.
Eslicarbazepin was treated with 0.5 mole equivalent of Lawesson's reagent in Toluene.
Reflux at 120°C gave a yellow liquid with white solids.
Purification with HPLC.
A sample was taken and given to mass spectrometry.
14.08.2018
The MS-Data was examined.
MS-Data gave a yield of >10%.
Drying of 1,2-dimethoxyethane with CaH2 overnight.
15.08.2018
Distillation of 1,2-dimethoxyethane, treating with N2 for inert storage.
16.08.2018
Alternative synthesis of the Thiol-Eslicarbazepin treated with 1,2-dimethoxyethane (DME) at room temperature with 0.5 mole equivalent of Lawesson's reagent, (method OH->SH).
17.08.2018
Drying the Thiol-Eslicarbazepin and purification by column chromatography (-> methods).
A sample was taken and given to mass spectrometry.
20.08.2018
The MS-Data was examined showed indications of large impurities.
Further purification of the Thiol-Eslicarbazepin by column chromatography.
21.08.2018
First attempt of the synthesis of the azide-Donor (method Azid-D). Sodium azide was suspended in Sulfuryl chloride and stirred overnight.
22.08.2018
The azide mixture was treated with Imidazole and dried in vacuo. After suspending in ethyl acetate the solution was treated with sulfuric acid to yield a crude, yellow solid.
A sample was taken and given to mass spectrometry.
23.08.2018
The MS-Data was showed no yield.
The second attempt for the synthesis of the azide-donor was started.
Sulfuryl chloride was treated with sodium azide and imidazole, suspended in acetonitrile and stirred for three hours.
The product was dried in vacuo, solved in ethyl acetate and treated with sulfuric acid. No product was obtained.
The third attempt for the synthesis of the azide-donor was started.
An ice-cooled Suspension of sodium azide in acetonitrile was treated with Sulfuryl chloride.
Synthesis Disulfide-Eslicarbazepine was started.
The synthesis was performed under inert conditions. The Thiol-Eslicarbazepin was solved in THF/H2O, treated with Cysteamine and stirred overnight.
24.08.2018
The ice-cooled solution of the azide was treated portion-wise with Imidazole.
It was stirred for three hours, diluted with ethyl acetate, washed, saturated and treated with sulfuric acid.
After stirring for one hour the crude, colorless product was obtained.
The product was dried in vacuo.
The solution of the S-S-Eslicarbazepine was in a rotary evaporator to obtain a crystalline, colorless solid.
27.08.2018
The S-S-Eslicarbazepine was further purified by washing with ethyl acetate.
A sample of the S-S-Eslicarbazepine was taken and given to mass spectrometry.
28.08.2018
The MS-Data was examined.
MS-Data suggested the reaction was not carried out as the original reactants were reobtained.
29.08.2018
The reactants were dried with a rotary evaporator for further use, but Thio-Eslicarbazepine was destroyed due to it's instability in water.
30.08.2018
Destroying of the azide-donor.
31.08.2018
Cleaning
Interlab
In this year, our team again decided to participate in the fifth international iGEM InterLab study, which aims to identify and correct the sources of systematic variability in synthetic biology measurements. The overall goal is that eventually, measurements taken in different labs will not underly the problems of variability due to different measurement environments or devices anymore, but will be reliable and comparable for all members of the science community.
The main question the InterLab Study 2018 tackeled was:
Can we reduce lab-to-lab variability in fluorescence measurements by normalizing to absolute cell count or colony-forming units (CFUs) instead of OD?
If you are interested to read more about our InterLab study results, click here: